US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 7.920
  • -0.190-2.34%
Trading Aug 28 11:03 ET
483.52MMarket Cap-1068P/E (TTM)

Sage Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
249.80%8.65M
139.89%7.9M
1,024.84%86.46M
2,621.54%77.97M
56.18%2.72M
64.82%2.47M
108.22%3.29M
21.85%7.69M
74.48%2.87M
20.76%1.74M
Operating revenue
-75.61%600K
-48.69%1.69M
36.01%10.45M
-30.72%1.99M
56.18%2.72M
63.89%2.46M
108.22%3.29M
21.85%7.69M
74.48%2.87M
20.76%1.74M
Cost of revenue
586.34%1.41M
451.74%1.27M
165.56%2.16M
473.43%820K
391.85%905K
2.50%205K
-19.58%230K
47.02%813K
64.37%143K
40.46%184K
Gross profit
219.39%7.25M
116.48%6.63M
1,126.48%84.3M
2,734.39%77.15M
16.46%1.81M
74.40%2.27M
136.42%3.06M
19.43%6.87M
75.05%2.72M
18.79%1.56M
Operating expense
-31.37%118.55M
-21.59%124.31M
13.88%630.76M
-23.74%119.44M
25.89%180.06M
33.13%172.73M
27.34%158.53M
18.69%553.86M
23.29%156.62M
8.19%143.04M
Selling and administrative expenses
-25.91%55.98M
-19.99%52.57M
20.56%274.52M
-18.15%55.11M
27.10%78.14M
36.04%75.57M
41.38%65.71M
24.09%227.7M
30.49%67.33M
26.23%61.48M
-General and administrative expense
-25.91%55.98M
-19.99%52.57M
20.56%274.52M
-18.15%55.11M
27.10%78.14M
36.04%75.57M
41.38%65.71M
24.09%227.7M
30.49%67.33M
26.23%61.48M
Research and development costs
-35.61%62.56M
-22.72%71.73M
9.22%356.24M
-27.96%64.33M
24.97%101.92M
25.70%97.16M
18.98%92.83M
15.18%326.16M
18.36%89.3M
-2.33%81.55M
Operating profit
34.70%-111.3M
24.31%-117.68M
0.10%-546.46M
72.52%-42.29M
-25.99%-178.25M
-32.71%-170.46M
-26.19%-155.47M
-18.68%-546.99M
-22.64%-153.9M
-8.09%-141.48M
Net non-operating interest income expense
-17.12%8.43M
4.24%9.2M
173.03%38.74M
39.36%9.47M
148.95%10.27M
383.97%10.17M
655.99%8.83M
392.20%14.19M
804.53%6.79M
496.39%4.13M
Non-operating interest income
-17.12%8.43M
4.24%9.2M
173.03%38.74M
39.36%9.47M
148.95%10.27M
383.97%10.17M
655.99%8.83M
392.20%14.19M
804.53%6.79M
496.39%4.13M
Other net income (expense)
136.59%15K
93.62%-12K
-225,226.67%-33.77M
408.11%114K
-112,280.00%-33.65M
-191.11%-41K
-683.33%-188K
-88.81%15K
-254.17%-37K
-3.23%30K
Special income (charges)
----
----
---33.39M
--213K
---33.6M
----
----
--0
--0
--0
-Less：Restructuring and merger&acquisition
----
----
--33.39M
---213K
--33.6M
----
----
--0
--0
--0
Other non- operating income (expenses)
136.59%15K
93.62%-12K
-2,653.33%-383K
-167.57%-99K
-283.33%-55K
-191.11%-41K
-683.33%-188K
-88.81%15K
-254.17%-37K
-3.23%30K
Income before tax
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.94%-160.33M
-20.30%-146.83M
-16.36%-532.78M
-17.99%-147.15M
-5.49%-137.32M
Income tax
Net income
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.94%-160.33M
-20.30%-146.83M
-16.36%-532.78M
-17.99%-147.15M
-5.49%-137.32M
Net income continuous Operations
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.94%-160.33M
-20.30%-146.83M
-16.36%-532.78M
-17.99%-147.15M
-5.49%-137.32M
Minority interest income
Net income attributable to the parent company
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.98%-160.33M
-20.30%-146.83M
-16.36%-532.78M
-17.99%-147.15M
-5.49%-137.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.98%-160.33M
-20.30%-146.83M
-16.36%-532.78M
-17.99%-147.15M
-5.49%-137.32M
Basic earnings per share
36.57%-1.7
26.83%-1.8
-0.78%-9.05
78.14%-0.54
-45.89%-3.37
-25.82%-2.68
-18.84%-2.46
-15.13%-8.98
-16.51%-2.47
-4.52%-2.31
Diluted earnings per share
36.57%-1.7
26.83%-1.8
-0.78%-9.05
78.14%-0.54
-45.89%-3.37
-25.82%-2.68
-18.84%-2.46
-15.13%-8.98
-16.51%-2.47
-4.52%-2.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 249.80%8.65M139.89%7.9M1,024.84%86.46M2,621.54%77.97M56.18%2.72M64.82%2.47M108.22%3.29M21.85%7.69M74.48%2.87M20.76%1.74M
Operating revenue -75.61%600K-48.69%1.69M36.01%10.45M-30.72%1.99M56.18%2.72M63.89%2.46M108.22%3.29M21.85%7.69M74.48%2.87M20.76%1.74M
Cost of revenue 586.34%1.41M451.74%1.27M165.56%2.16M473.43%820K391.85%905K2.50%205K-19.58%230K47.02%813K64.37%143K40.46%184K
Gross profit 219.39%7.25M116.48%6.63M1,126.48%84.3M2,734.39%77.15M16.46%1.81M74.40%2.27M136.42%3.06M19.43%6.87M75.05%2.72M18.79%1.56M
Operating expense -31.37%118.55M-21.59%124.31M13.88%630.76M-23.74%119.44M25.89%180.06M33.13%172.73M27.34%158.53M18.69%553.86M23.29%156.62M8.19%143.04M
Selling and administrative expenses -25.91%55.98M-19.99%52.57M20.56%274.52M-18.15%55.11M27.10%78.14M36.04%75.57M41.38%65.71M24.09%227.7M30.49%67.33M26.23%61.48M
-General and administrative expense -25.91%55.98M-19.99%52.57M20.56%274.52M-18.15%55.11M27.10%78.14M36.04%75.57M41.38%65.71M24.09%227.7M30.49%67.33M26.23%61.48M
Research and development costs -35.61%62.56M-22.72%71.73M9.22%356.24M-27.96%64.33M24.97%101.92M25.70%97.16M18.98%92.83M15.18%326.16M18.36%89.3M-2.33%81.55M
Operating profit 34.70%-111.3M24.31%-117.68M0.10%-546.46M72.52%-42.29M-25.99%-178.25M-32.71%-170.46M-26.19%-155.47M-18.68%-546.99M-22.64%-153.9M-8.09%-141.48M
Net non-operating interest income expense -17.12%8.43M4.24%9.2M173.03%38.74M39.36%9.47M148.95%10.27M383.97%10.17M655.99%8.83M392.20%14.19M804.53%6.79M496.39%4.13M
Non-operating interest income -17.12%8.43M4.24%9.2M173.03%38.74M39.36%9.47M148.95%10.27M383.97%10.17M655.99%8.83M392.20%14.19M804.53%6.79M496.39%4.13M
Other net income (expense) 136.59%15K93.62%-12K-225,226.67%-33.77M408.11%114K-112,280.00%-33.65M-191.11%-41K-683.33%-188K-88.81%15K-254.17%-37K-3.23%30K
Special income (charges) -----------33.39M--213K---33.6M----------0--0--0
-Less：Restructuring and merger&acquisition ----------33.39M---213K--33.6M----------0--0--0
Other non- operating income (expenses) 136.59%15K93.62%-12K-2,653.33%-383K-167.57%-99K-283.33%-55K-191.11%-41K-683.33%-188K-88.81%15K-254.17%-37K-3.23%30K
Income before tax 35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.94%-160.33M-20.30%-146.83M-16.36%-532.78M-17.99%-147.15M-5.49%-137.32M
Income tax
Net income 35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.94%-160.33M-20.30%-146.83M-16.36%-532.78M-17.99%-147.15M-5.49%-137.32M
Net income continuous Operations 35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.94%-160.33M-20.30%-146.83M-16.36%-532.78M-17.99%-147.15M-5.49%-137.32M
Minority interest income
Net income attributable to the parent company 35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.98%-160.33M-20.30%-146.83M-16.36%-532.78M-17.99%-147.15M-5.49%-137.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.98%-160.33M-20.30%-146.83M-16.36%-532.78M-17.99%-147.15M-5.49%-137.32M
Basic earnings per share 36.57%-1.726.83%-1.8-0.78%-9.0578.14%-0.54-45.89%-3.37-25.82%-2.68-18.84%-2.46-15.13%-8.98-16.51%-2.47-4.52%-2.31
Diluted earnings per share 36.57%-1.726.83%-1.8-0.78%-9.0578.14%-0.54-45.89%-3.37-25.82%-2.68-18.84%-2.46-15.13%-8.98-16.51%-2.47-4.52%-2.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg